17
results
for author:"Bi W."
in Literature Citations
| Increased LIS1 expression affects human and mouse brain development. Bi W., Sapir T., Shchelochkov O.A., Zhang F., Withers M.A., Hunter J.V., Levy T., Shinder V., Peiffer D.A., Gunderson K.L. et al. Nat. Genet. 41:168-177(2009) · Mapped (3) |
| Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. Klunk W.E., Price J.C., Mathis C.A., Tsopelas N.D., Lopresti B.J., Ziolko S.K., Bi W., Hoge J.A., Cohen A.D., Ikonomovic M.D. et al. J. Neurosci. 27:6174-6184(2007) · Mapped (5) |
| Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Bi W., Yan J., Shi X., Yuva-Paylor L.A., Antalffy B.A., Goldman A., Yoo J.W., Noebels J.L., Armstrong D.L., Paylor R. et al. Hum. Mol. Genet. 16:1802-1813(2007) · Mapped (7) |
| Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Shelbourne P.F., Keller-McGandy C., Bi W.L., Yoon S.R., Dubeau L., Veitch N.J., Vonsattel J.P., Wexler N.S., Arnheim N., Augood S.J. Hum. Mol. Genet. 16:1133-1142(2007) · Mapped (3) |
| Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux. Lu W., van Eerde A.M., Fan X., Quintero-Rivera F., Kulkarni S., Ferguson H., Kim H.-G., Fan Y., Xi Q., Li Q.-G. et al. Am. J. Hum. Genet. 80:616-632(2007) · UniProtKB (2) · Mapped (18) |
| Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike. Yan J., Bi W., Lupski J.R. Am. J. Hum. Genet. 80:518-525(2007) · Mapped (71) |
| Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). Walz K., Paylor R., Yan J., Bi W., Lupski J.R. J. Clin. Invest. 116:3035-3041(2006) · Mapped (13) |
| Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Eichers E.R., Abd-El-Barr M.M., Paylor R., Lewis R.A., Bi W., Lin X., Meehan T.P., Stockton D.W., Wu S.M., Lindsay E. et al. Hum. Genet. 120:211-226(2006) · Mapped (2) |
| MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Vong L., Bi W., O'Connor-Halligan K.E., Li C., Cserjesi P., Schwarz J.J. Dev. Dyn. 235:1809-1821(2006) · Mapped (14) |
| DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K. et al. Nature 440:1045-1049(2006) · UniProtKB (913) |
| Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Viapiano M.S., Bi W.L., Piepmeier J., Hockfield S., Matthews R.T. Cancer Res. 65:6726-6733(2005) · Mapped (9) |
| Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Bi W., Ohyama T., Nakamura H., Yan J., Visvanathan J., Justice M.J., Lupski J.R. Hum. Mol. Genet. 14:983-995(2005) · UniProtKB (1) · Mapped (6) |
| Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Bi W., Saifi G.M., Shaw C.J., Walz K., Fonseca P., Wilson M., Potocki L., Lupski J.R. |
| Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Bi W., Yan J., Stankiewicz P., Park S.-S., Walz K., Boerkoel C.F., Potocki L., Shaffer L.G., Devriendt K., Nowaczyk M.J.M. et al. Genome Res. 12:713-728(2002) · UniProtKB (7) |
| Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Proc. Natl. Acad. Sci. U.S.A. 98:6698-6703(2001) · Mapped (29) |
| The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Bi W., Drake C.J., Schwarz J.J. Dev. Biol. 211:255-267(1999) · Mapped (37) |
| Sox9 is required for cartilage formation. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Nat. Genet. 22:85-89(1999) · Mapped (22) |
